BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34089986)

  • 1. Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors.
    Narendra G; Raju B; Verma H; Sapra B; Silakari O
    J Mol Graph Model; 2021 Sep; 107():107950. PubMed ID: 34089986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
    Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach.
    Narendra G; Raju B; Verma H; Kumar M; Jain SK; Tung GK; Thakur S; Kaur R; Kaur S; Sapra B; Singh PK; Silakari O
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124749. PubMed ID: 37160174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
    Li B; Yang K; Liang D; Jiang C; Ma Z
    Eur J Med Chem; 2021 Jan; 209():112940. PubMed ID: 33328099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
    Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors.
    Omran Z
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1.
    Raju B; Verma H; Narendra G; Sapra B; Silakari O
    J Biomol Struct Dyn; 2022 Oct; 40(17):7975-7990. PubMed ID: 33769194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.
    Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
    Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V
    Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
    Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
    Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new disulfiram analogues as ALDH1a1-selective inhibitors.
    Omran Z
    Bioorg Med Chem Lett; 2021 May; 40():127958. PubMed ID: 33744437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M
    Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia.
    Dancik GM; Voutsas IF; Vlahopoulos S
    Mol Biol Rep; 2022 Apr; 49(4):3321-3331. PubMed ID: 35028852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole as a potent activator of human cytosolic aldehyde dehydrogenase ALDH1A1.
    Calleja LF; Belmont-Díaz JA; Medina-Contreras O; Quezada H; Yoval-Sánchez B; Campos-García J; Rodríguez-Zavala JS
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129451. PubMed ID: 31678145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.
    Narendra G; Raju B; Verma H; Kumar M; Jain SK; Tung GK; Thakur S; Kaur R; Kaur S; Sapra B; Silakari O
    RSC Med Chem; 2024 Jan; 15(1):309-321. PubMed ID: 38283216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
    Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
    Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
    Ma Z; Jiang L; Li G; Liang D; Li L; Liu L; Jiang C
    Bioorg Chem; 2020 Aug; 101():103971. PubMed ID: 32480173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
    Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C
    Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
    Morgan CA; Hurley TD
    Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
    Morgan CA; Hurley TD
    J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.